4/3/2003 5:25 AM
A drug that helps stop destructive cells from breaching the blood-brain
barrier is reducing new brain lesions for Multiple Sclerosis patients by
93 percent. Antegren is part of a new class of drugs called Selective Adhesion
Molecule Inhibitors, or SAM Inhibitors. The drug prevents immune cells
from passing through capillaries in the brain. By stopping these cells,
the brain and a protective sheath for nerves, are protected from the invading
cells. Antegren is administered in weekly IV infusions. Itís also being
explored for treatment of Crohnís disease.
Copyright © 2003 TWEAN Newschannel of Raleigh, L.L.C.